GRI
GRI Bio Inc.
NASDAQ: GRI · HEALTHCARE · BIOTECHNOLOGY
$1.63
+2.85% today
Updated 2026-10-28
Market cap
$3.55M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-14.53
Dividend yield
—
52W range
$1 – $64
Volume
0.3M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.5
Quality
B3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-10.7
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →271 stocks currently score above 75
Price targets
Analyst target
$18.50
+1038.46%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -10.73 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-1.45M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $21.77M | $22.54M | $0.00 | $0.00 |
| Net income | $-3.22M | $-13.04M | $-8.21M | $-11.96M | $-1.64M |
| EPS | — | — | — | — | $-14.53 |
| Free cash flow | $-1.09M | $-9.00M | $-8.61M | $-10.19M | $-1.45M |
| Profit margin | — | -59.89% | -36.41% | — | — |
Peer comparison
Smart narrative
GRI Bio Inc. trades at $1.63. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -10.73, it sits in the distress.
Frequently asked questions
What is GRI Bio Inc.'s stock price?
GRI Bio Inc. (GRI) trades at $1.63.
Is GRI Bio Inc. overvalued?
GRI Bio Inc. carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of GRI Bio Inc. (GRI)?
The 12-month analyst consensus target is $18.50, about 1038.5% above the current $1.63. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
GRI Bio Inc.'s Altman Z-Score is -10.73, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-103.44%
Beta-0.61
50D MA$1.82
200D MA$2.28
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—